Mitochondrial transcription factor a and mitochondrial genome as molecular targets for cisplatin-based cancer chemotherapy

Kimitoshi Kohno, Ke Yong Wang, Mayu Takahashi, Tomoko Kurita, Yoichiro Yoshida, Masakazu Hirakawa, Yoshikazu Harada, Akihiro Kuma, Hiroto Izumi, Shinji Matsumoto

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Mitochondria are important cellular organelles that function as control centers of the energy supply for highly proliferative cancer cells and regulate apoptosis after cancer chemotherapy. Cisplatin is one of the most important chemotherapeutic agents and a key drug in therapeutic regimens for a broad range of solid tumors. Cisplatin may directly interact with mitochondria, which can induce apoptosis. The direct interactions between cisplatin and mitochondria may account for our understanding of the clinical activity of cisplatin and development of resistance. However, the basis for the roles of mitochondria under treatment with chemotherapy is poorly understood. In this review, we present novel aspects regarding the unique characteristics of the mitochondrial genome in relation to the use of platinum-based chemotherapy and describe our recent work demonstrating the importance of the mitochondrial transcription factor A (mtTFA) expression in cancer cells.

Original languageEnglish
Pages (from-to)19836-19850
Number of pages15
JournalInternational journal of molecular sciences
Volume16
Issue number8
DOIs
Publication statusPublished - Aug 20 2015

Fingerprint

Mitochondria
Transcription factors
Mitochondrial Genome
mitochondria
Chemotherapy
genome
chemotherapy
Cisplatin
Transcription Factors
Genes
cancer
Drug Therapy
apoptosis
Cell death
Neoplasms
drugs
Cells
Apoptosis
organelles
Platinum

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Mitochondrial transcription factor a and mitochondrial genome as molecular targets for cisplatin-based cancer chemotherapy. / Kohno, Kimitoshi; Wang, Ke Yong; Takahashi, Mayu; Kurita, Tomoko; Yoshida, Yoichiro; Hirakawa, Masakazu; Harada, Yoshikazu; Kuma, Akihiro; Izumi, Hiroto; Matsumoto, Shinji.

In: International journal of molecular sciences, Vol. 16, No. 8, 20.08.2015, p. 19836-19850.

Research output: Contribution to journalReview article

Kohno, K, Wang, KY, Takahashi, M, Kurita, T, Yoshida, Y, Hirakawa, M, Harada, Y, Kuma, A, Izumi, H & Matsumoto, S 2015, 'Mitochondrial transcription factor a and mitochondrial genome as molecular targets for cisplatin-based cancer chemotherapy', International journal of molecular sciences, vol. 16, no. 8, pp. 19836-19850. https://doi.org/10.3390/ijms160819836
Kohno, Kimitoshi ; Wang, Ke Yong ; Takahashi, Mayu ; Kurita, Tomoko ; Yoshida, Yoichiro ; Hirakawa, Masakazu ; Harada, Yoshikazu ; Kuma, Akihiro ; Izumi, Hiroto ; Matsumoto, Shinji. / Mitochondrial transcription factor a and mitochondrial genome as molecular targets for cisplatin-based cancer chemotherapy. In: International journal of molecular sciences. 2015 ; Vol. 16, No. 8. pp. 19836-19850.
@article{b109b4a8894a463c9452e7f407ae4e70,
title = "Mitochondrial transcription factor a and mitochondrial genome as molecular targets for cisplatin-based cancer chemotherapy",
abstract = "Mitochondria are important cellular organelles that function as control centers of the energy supply for highly proliferative cancer cells and regulate apoptosis after cancer chemotherapy. Cisplatin is one of the most important chemotherapeutic agents and a key drug in therapeutic regimens for a broad range of solid tumors. Cisplatin may directly interact with mitochondria, which can induce apoptosis. The direct interactions between cisplatin and mitochondria may account for our understanding of the clinical activity of cisplatin and development of resistance. However, the basis for the roles of mitochondria under treatment with chemotherapy is poorly understood. In this review, we present novel aspects regarding the unique characteristics of the mitochondrial genome in relation to the use of platinum-based chemotherapy and describe our recent work demonstrating the importance of the mitochondrial transcription factor A (mtTFA) expression in cancer cells.",
author = "Kimitoshi Kohno and Wang, {Ke Yong} and Mayu Takahashi and Tomoko Kurita and Yoichiro Yoshida and Masakazu Hirakawa and Yoshikazu Harada and Akihiro Kuma and Hiroto Izumi and Shinji Matsumoto",
year = "2015",
month = "8",
day = "20",
doi = "10.3390/ijms160819836",
language = "English",
volume = "16",
pages = "19836--19850",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "8",

}

TY - JOUR

T1 - Mitochondrial transcription factor a and mitochondrial genome as molecular targets for cisplatin-based cancer chemotherapy

AU - Kohno, Kimitoshi

AU - Wang, Ke Yong

AU - Takahashi, Mayu

AU - Kurita, Tomoko

AU - Yoshida, Yoichiro

AU - Hirakawa, Masakazu

AU - Harada, Yoshikazu

AU - Kuma, Akihiro

AU - Izumi, Hiroto

AU - Matsumoto, Shinji

PY - 2015/8/20

Y1 - 2015/8/20

N2 - Mitochondria are important cellular organelles that function as control centers of the energy supply for highly proliferative cancer cells and regulate apoptosis after cancer chemotherapy. Cisplatin is one of the most important chemotherapeutic agents and a key drug in therapeutic regimens for a broad range of solid tumors. Cisplatin may directly interact with mitochondria, which can induce apoptosis. The direct interactions between cisplatin and mitochondria may account for our understanding of the clinical activity of cisplatin and development of resistance. However, the basis for the roles of mitochondria under treatment with chemotherapy is poorly understood. In this review, we present novel aspects regarding the unique characteristics of the mitochondrial genome in relation to the use of platinum-based chemotherapy and describe our recent work demonstrating the importance of the mitochondrial transcription factor A (mtTFA) expression in cancer cells.

AB - Mitochondria are important cellular organelles that function as control centers of the energy supply for highly proliferative cancer cells and regulate apoptosis after cancer chemotherapy. Cisplatin is one of the most important chemotherapeutic agents and a key drug in therapeutic regimens for a broad range of solid tumors. Cisplatin may directly interact with mitochondria, which can induce apoptosis. The direct interactions between cisplatin and mitochondria may account for our understanding of the clinical activity of cisplatin and development of resistance. However, the basis for the roles of mitochondria under treatment with chemotherapy is poorly understood. In this review, we present novel aspects regarding the unique characteristics of the mitochondrial genome in relation to the use of platinum-based chemotherapy and describe our recent work demonstrating the importance of the mitochondrial transcription factor A (mtTFA) expression in cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=84939825681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939825681&partnerID=8YFLogxK

U2 - 10.3390/ijms160819836

DO - 10.3390/ijms160819836

M3 - Review article

C2 - 26307971

AN - SCOPUS:84939825681

VL - 16

SP - 19836

EP - 19850

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 8

ER -